Once non-small-cell lung cancer (NSCLC) spreads far and wide ... Cancer comes about when a gene change causes a cell to grow and divide out of control. But you have so many genes, it's often ...

Small-cell lung cancer (SCLC) is one of the most aggressive and deadly types of cancer, often linked to smoking. Although it ...

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

Topline data were announced from a phase 3 trial evaluating tarlatamab for the treatment of SCLC in patients who progressed on or after a single line of platinum-based chemotherapy.

The Small Cell Lung Cancer market report also offers comprehensive insights into the Small Cell Lung Cancer market size, ...

Purdue University scientists have identified the Supinoxin molecule as a possible new therapy for small cell lung cancer.

Even with prevention measures and timely, aggressive intervention, tumor lysis syndrome (TLS) remains life-threatening, as a ...

If certain proteins attach to PD-1 receptors, this causes immune cells to stop ... found Opdivo to be effective for treating non-small cell lung cancer (NSCLC) in adults. One trial found that ...

An FDA-designated orphan drug that can target a key vulnerability in lung cancer shows promise in improving the efficacy of ...

Non-small cell lung cancer (NSCLC) remains one of the leading causes of cancer-related deaths globally, and Ghana is no ...

To see whether immunotherapy keeps working even after it’s stopped, researchers evaluated data from nearly 2,800 patients ...